|Day Low/High||84.64 / 85.33|
|52 Wk Low/High||60.32 / 85.36|
- Afinion™ HbA1c Dx test provides results in three minutes, enabling clinicians to develop informed, individualized care plans during patient consultation
A quiet week offered a chance to get ready for volatility around the FOMC meeting and G-20 summit later this month.
ABBOTT PARK, Ill., June 14, 2019 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 32 cents per share.
- 45% of blood donations have historically come from people over 50 years old, but that number is declining1
- Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has a positive impact among adults with Type 2 Diabetes who use multiple injections of insulin daily
We'll trim shares of Comcast and use that to finance a purchase in Kohl's.
We think Abbott Labs is a terrific company, but the stock already has a big premium and that may limit the potential of future gains.
Ironically, some experts now see biotech as a safe haven as the sector remains unaffected by trade wars and other global headwinds.
Stocks falter on realization that trade war between U.S. and China is about more than soybeans.
- Late-breaking data for Abbott's investigational clip-based tricuspid heart valve repair system presented at EuroPCR
In this market of haves and have-nots, too many stocks are still languishing and sentiment is sour -- but we're still likely oversold enough to potentially rally this week.
Jim Cramer says we'll need to pay close attention to retailers' earnings. Here's your game plan for next week.
Jim Cramer weighs in on Arena Pharmaceuticals, DaVita, Merck, Abbott Laboratories, IAC Interactive, Yext and more.
These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.
- The YouGov-Abbott Student Loan Impact Survey shows 87% of those in college or graduating this year with student debt say finding a company with a student loan benefit is important to them
- Partnership with NIH aims to increase understanding and accelerate the application of neurostimulation therapies
Now that our cash levels are even more flushed than before, we believe we have prudently acted for the uncertainty we face this week.
There is room here to take even more off the table and lock in some of the big gains.
ABBOTT PARK, Ill., May 7, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the UBS Global Healthcare Conference on Tuesday, May 21, 2019.
WORLD'S FIRST SMARTPHONE-COMPATIBLE IMPLANTABLE HEART MONITOR, ABBOTT'S CONFIRM Rx™ ICM OFFERS MORE ACCURATE DETECTION OF HEART RHYTHM DISORDERS
- WHO Prequalification approval allows Abbott to bring critical technology to more resource-limited settings
-- Academic, military and healthcare leaders have come together to conduct a scientifically rigorous clinical trial of a blood test in development for the brain
- Research found Abbott's High-Sensitive Troponin-I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.